RecruitingNot ApplicableNCT07245862

Evaluation of a Family-centered Program for Problematic Gaming/Excessive Screen Use

Evaluation of a Family-centered Program for Problematic Gaming/Excessive Screen Use in a Child and Adolescent Population Within Social Services in Light of the New Social Services Law


Sponsor

Region Skane

Enrollment

170 participants

Start Date

Jan 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The Family-Centered Program for Problematic Gaming and Excessive Screen Use (FAME) is a pioneering initiative designed to address the growing challenges of excessive screen use and gaming among children and adolescents, particularly within family dynamics.


Eligibility

Min Age: 11 YearsMax Age: 14 Years

Inclusion Criteria2

  • family conflicts related to screen use
  • spaeks and udnerstand swedish

Exclusion Criteria1

  • se above

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALFamily-centered Program for Problematic Gaming/Excessive Screen Use in a child and adolescent population within Social Services

The critical components include psychoeducation, cognitive restructuring, and social and emotional learning.his would be the first intervention offering help for both children and their parents. Such an intervention could be beneficial not only to individual families, but also to society at large by reducing societal costs, enhancing family well-being, and addressing health inequalities . the intervention is agroup intervention in 4 sessions with parents in one group and children in one group. The goals are to help children and parents understand the positive and negative aspects of screen use and to prevent related problems and family conflicts. T

BEHAVIORALControl

This group will recieve TAU == treat ment as usual depending on the practice at the Social service they belong to


Locations(1)

Child and Adolescent Psychiatry Clinic

Lund, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07245862


Related Trials